Out of Business:
Grifols Recombinant Protein CDMO provides CDMO services for bulk recombinant proteins produced by microbial and mammalian expression systems for use in diagnostics, therapeutics and vaccines. Based in the San Francisco Bay Area, they have three decades of process development and GMP manufacturing experience, and they support long-term relationships through expertise, quality, and reliability.